Overview. The mission of the OSCTR is to serve as a catalyst to facilitate clinical research into relevant health improvements for underserved and underrepresented populations living in rural areas, to improve patient outcomes, and to provide these resources to investigators and patients from other IDeA states. Thus, the OSCTR and its collaborating partners have identified the following goals: (1) Enhance the development of high-caliber OSCTR clinical translational scientists who focus on health issues of concern to our populations through training, mentoring and pilot grant opportunities, (2) Establish the OSCTR Research Navigator Service to facilitate access to research infrastructure, (3) Develop and share infrastructure to support Clinical and Translational Research (CTR) throughout Oklahoma, Kansas, Arkansas, South Carolina, Alaska and future collaborating IDeA states, (4) Promote research on diseases with high prevalence among American Indians and Alaskan Natives, (5) Utilize and build registries and repositories to better understand disease mechanisms and to help launch junior OSCTR clinical investigative careers, (6) Engage communities through practice based research networks to identify and conduct research of highest interest to Oklahoma and other IDeA communities, (7) Mentor early stage OSCTR clinical investigators to research independence. Preliminary assessment reveals the complexity of the project, as it involves multiple institutions combining strengths in basic and applied research, clinical service, and practice research to enhance clinical care outcomes, particularly in addressing the needs of special populations. The proposed evaluation will work with the distinctiveness of this application to address the needs of stakeholders (broadly defined, e.g., OSCTR investigators, trainees, staff, community members) in the realization of the OSCTR goals. The Evaluation Core will rigorously evaluate the overall operational functions of the OSCTR and Key Component Activities (KCAs) and outcomes. In this proposal, we set out a broad plan to evaluate implementation of short-term and long-term goals using a goals-based evaluation framework and logic model (Figure 1). We will do this for the OSCTR as a whole, and will facilitate this level of evaluation within each of the KCAs. Note that KCA leaders have proposed specific milestones and tracking measures for the success of their operations in the activity and timeline tables later in this section. These primarily focus on process measures and represent one level of OSCTR evaluation

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
1U54GM104938-01A1
Application #
8608749
Study Section
Special Emphasis Panel (ZGM1-TWD-C (CC))
Project Start
Project End
Budget Start
2013-09-01
Budget End
2014-06-30
Support Year
1
Fiscal Year
2013
Total Cost
$151,639
Indirect Cost
$49,180
Name
University of Oklahoma Health Sciences Center
Department
Type
DUNS #
878648294
City
Oklahoma City
State
OK
Country
United States
Zip Code
73117
Rostaminia, Ghazaleh; Peck, Jennifer D; Quiroz, Lieschen H et al. (2016) Characteristics associated with pelvic organ prolapse in women with significant levator ani muscle deficiency. Int Urogynecol J 27:261-7
Munroe, Melissa E; Young, Kendra A; Kamen, Diane L et al. (2016) Soluble Mediators and Clinical Features Discern Risk of Transitioning to Classified Disease in Relatives of Systemic Lupus Erythematosus Patients. Arthritis Rheumatol :
Rabadi, Meheroz H; Aston, Christopher E (2016) Compare serum creatinine versus Renal (99m)Tc-DTPA scan determined glomerular filtration rates in veterans with traumatic spinal cord injury and meurogenic bladder. J Spinal Cord Med 39:638-644
Sandhya, Pulukool; Kurien, Biji Theyilamannil; Danda, Debashish et al. (2016) Update on Pathogenesis of Sjögren's syndrome. Curr Rheumatol Rev :
Hannafon, Bethany N; Trigoso, Yvonne D; Calloway, Cameron L et al. (2016) Plasma exosome microRNAs are indicative of breast cancer. Breast Cancer Res 18:90
Young, Kendra A; Munroe, Melissa E; Guthridge, Joel M et al. (2016) Combined role of vitamin D status and CYP24A1 in the transition to systemic lupus erythematosus. Ann Rheum Dis :
Wolska, Nina; Rybakowska, Paulina; Rasmussen, Astrid et al. (2016) Brief Report: Patients With Primary Sjögren's Syndrome Who Are Positive for Autoantibodies to Tripartite Motif-Containing Protein 38 Show Greater Disease Severity. Arthritis Rheumatol 68:724-9
Heu, May Kou; Welborn, Toney; Nagykaldi, Zsolt (2016) Clinical Question: In adult patients on warfarin, does-home-self-testing of prothrombin time and/or international normalized ratio provide the same outcomes compared to testing by a home health nurse or in a clinical setting? J Okla State Med Assoc 109:99-100
Bonney, Phillip A; Maurer, Adrian J; Cheema, Ahmed A et al. (2016) Clinical significance of changes in pB-C2 distance in patients with Chiari Type I malformations following posterior fossa decompression: a single-institution experience. J Neurosurg Pediatr 17:336-42
Lu, Rufei; Munroe, Melissa E; Guthridge, Joel M et al. (2016) Dysregulation of innate and adaptive serum mediators precedes systemic lupus erythematosus classification and improves prognostic accuracy of autoantibodies. J Autoimmun 74:182-193

Showing the most recent 10 out of 134 publications